Clinical Trials 2015TARGETED THERAPY: TREATMENT OPTIONS IN ALK REARRANGED NON SMALL CELL LUNG CANCERS WHICH ARE…ALK is member of a family of proteins present on the surface of the cell called Receptor Tyrosine Kinase. These proteins are responsible…Nov 6, 2016Nov 6, 2016
Clinical Trials 2015FDA modify the Dosage Regimen for OPDIVO (Nivolumab)Opdivo is is one of the leading new immunotherapy agent which is now being used in the following advanced stage cancer types 1) Renal cell…Nov 4, 2016Nov 4, 2016
Clinical Trials 2015TARGETED THERAPY: TAGRISSO (osimertinib) IN SQUAMOUS CELL LUNG CANCERLung cancer is the leading cause of cancer death in the United States, with an estimated 221,200 new diagnoses and 158,040 deaths in 2015…Nov 4, 2016Nov 4, 2016
Clinical Trials 2015TARGETED THERAPY: FDA APPROVES OLARATUMAB (LARTRUVO) WITH DOXORUBICIN FOR THE TREATMENT OF SOFT…Soft tissue sarcomas (STS) are very aggressive type of cancers. STS includes a wide variety of tumors arising in the muscle, fat, blood…Nov 4, 2016Nov 4, 2016
Clinical Trials 2015TARGETED THERAPY: ATEZOLIZUMABAtezolizumab is a type of Immunotherapy, which works by stimulating the immune system to destroy cancer cells. Immune system is the defense…Oct 2, 2016Oct 2, 2016
Clinical Trials 2015SEARCH FOR CLINICAL TRIALSThe best site to look for a clinical trials is clinicaltrials.govOct 1, 2016Oct 1, 2016
Clinical Trials 2015UNDERSTANDING CLINICAL RESEARCH AND CLINICAL TRIALSCLINICAL TRIALS http://www.fda.gov/…/ForWomen/FreePublications/UCM237816.pdf http://www.centerwatch.com/clinical-trials/volunteering.aspx…Oct 1, 2016Oct 1, 2016
Clinical Trials 2015Clinical Trials 2015A PATIENT RESOURCE FOR TARGETED THERAPIESOct 1, 2016Oct 1, 2016
